Anti-Cancer Agents and Biological Therapy
Clinical Pharmacology of Anti-Cancer Agents
Oncological Emergencies
Latest ESMO videos
Featured medwireNews
Carboplatin–Paclitaxel Recommended For Elderly Advanced Ovarian Cancer Patients
Adding Copanlisib To Rituximab Improves PFS In Relapsed Indolent NHL
CheckMate 816 Shows Benefit Of Neoadjuvant Nivolumab–Chemotherapy For Operable NSCLC
Second-Line FOLFOX May Become ‘Standard Of Care’ For Advanced Biliary Tract Cancer
Adjuvant PD-1 Inhibitor Chronic Immune-Related AEs Highlighted In Advanced Melanoma
E-Learning
ESMO E-Learning: Cardiotoxicity in Oncology Practice
ESMO E-Learning: Multimodular Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)
ESMO V-Learning: BRCA Across Tumour Types
ESMO E-Learning: Next Generation Drugs in Kidney Cancer
ESMO E-Learning: Management of Cancer Associated Thrombosis
Meeting resources
Next wave of ADCs: New targets, new drugs, new indications
Presenter: Valentina Boni
Session: Early drug development in breast cancer
Resources:
Slides
Webcast
LBA2 - Impact of RNA expression signatures and tumor infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial.
Presenter: Monika Graeser
Session: Proffered Paper session 2
Resources:
Abstract
Slides
Webcast
Progression after CDK 4/6i: New kids on the block
Presenter: Philippe Aftimos
Session: Optimal sequence in metastatic ER+ breast cancer
Resources:
Slides
Webcast
Pharmacokinetic differences and ethnic variability in tolerance of cytotoxic drugs
Presenter: Romano Danesi
Session: Impact of ethnicity-based differences in breast cancer
Resources:
Slides
Webcast
2O - Association of RAD51 with Homologous Recombination Deficiency (HRD) and clinical outcomes in untreated triple-negative breast cancer (TNBC): analysis of the GeparSixto randomized clinical trial
Presenter: Alba Llop-Guevara
Session: Proffered Paper session 1
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
-
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and can only be disabled by changing your browser preferences.